Cabaletta Bio (CABA) Free Cash Flow (2018 - 2025)

Cabaletta Bio's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$34.3 million for Q4 2025.

• In Q4 2025, Free Cash Flow fell 46.05% year-over-year to -$34.3 million; the TTM figure through Dec 2025 stood at -$131.1 million (down 44.95% YoY), while the FY2025 annual figure was -$131.1 million, down 44.95% from the prior year.
• Free Cash Flow was -$34.3 million for Q4 2025 at Cabaletta Bio, up from -$35.5 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$6.7 million in Q2 2021 to a low of -$35.5 million in Q3 2025.
• Historically, Free Cash Flow has averaged -$17.9 million across 5 years, with a median of -$13.0 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Free Cash Flow rose 13.88% in 2022, then slumped 89.79% in 2024.
• A 5-year view of Free Cash Flow shows it stood at -$11.6 million in 2021, then gained by 13.88% to -$10.0 million in 2022, then plunged by 66.58% to -$16.6 million in 2023, then slumped by 41.15% to -$23.5 million in 2024, then tumbled by 46.05% to -$34.3 million in 2025.
• The last three Free Cash Flow figures came in at -$34.3 million (Q4 2025), -$35.5 million (Q3 2025), and -$30.5 million (Q2 2025), per Business Quant data.